Compare CVS Health Corp (CVS) vs QUALCOMM, Inc. (QCOM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs QUALCOMM, Inc. — how do they compare? CVS Health Corp trades at $106.03 (market cap $135.12B), while QUALCOMM, Inc. trades at $180 (market cap $193.91B). The key difference: QUALCOMM, Inc. is the larger of the two by market cap, and CVS Health Corp pays the higher dividend (2.51%). Which is the better fit depends on your goals.
| CVS | QCOM | |
|---|---|---|
Market Cap | $135.12B | $193.91B |
Sector | Health | Technology |
52-Week High | $106.18 | $251.10 |
52-Week Low | $58.75 | $124.07 |
Enterprise Value | $201.66B | $199.39B |
Dividend Yield | 2.51% | 2% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $105.9, up 1.68% recently, with a bullish technical signal and strong analyst support (84.6% buy ratings). The company has beaten earnings estimates for three consecutive quarters, including Q1 2026 EPS of $2.57 versus $2.18 expected. Revenue growth remains robust, reaching $402.07B in 2025, though net margins are thin at 0.72%. Recent news highlights a settlement with the FTC advancing prescription drug affordability initiatives.
The outlook is positive given earnings momentum and strategic positioning in healthcare services, but risks include regulatory pressures and margin compression. The consensus price target of $110.62 suggests modest upside from current levels, supported by dividend payments and institutional confidence.
Qualcomm (QCOM) trades at $178.08, down 5.86% over 24 hours, with a bearish technical signal and mixed sentiment. The stock shows strong profitability with a 22.31% net income margin and consistent earnings beats in recent quarters. Recent news highlights its AI and data center diversification amid smartphone market challenges, with CEO Cristiano Amon projecting 'multiple billions' in data center revenue ahead (MarketBeat, June 2, 2026).
The outlook balances growth in AI and automotive against near-term margin pressures and competition. Analysts see upside to a $222.53 consensus target, but risks include Nvidia's entry into PC chips and soft smartphone demand. The stock offers value at a P/E of 19.78, with dividends providing income support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About QUALCOMM, Inc.
Qualcomm develops and licenses wireless technology and designs chips for smartphones. The company's key patents revolve around CDMA and OFDMA technologies, which are standards in wireless communications that are the backbone of all 3G and 4G networks. The firm is a leader in 5G network technology as well. Qualcomm's IP is licensed by virtually all wireless device makers. The firm is also the world's largest wireless chip vendor, supplying nearly every premier handset maker with leading-edge processors. Qualcomm also sells RF-front end modules into smartphones and chips into automotive and Internet of Things markets.
Read more on QCOM →
